Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink

The study evaluated possible associations between neurodevelopmental disorders (NDs) and exposure to mercury (Hg) from Thimerosal-containing vaccines (TCVs) by examining the automated Vaccine Safety Datalink (VSD). A total of 278,624 subjects were identified in birth cohorts from 1990-1996 that had received their first oral polio vaccination by 3 months of age in the VSD. The birth cohort prevalence rate of medically diagnosed International Classification of Disease, 9th revision (ICD-9) specific NDs and control outcomes were calculated. Exposures to Hg from TCVs were calculated by birth cohort for specific exposure windows from birth-7 months and birth-13 months of age. Poisson regression analysis was used to model the association between the prevalence of outcomes and Hg doses from TCVs. Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs. Routine childhood vaccination should be continued to help reduce the morbidity and mortality associated with infectious diseases, but efforts should be undertaken to remove Hg from vaccines. Additional studies should be conducted to further evaluate the relationship between Hg exposure and NDs.

[1]  E. Faustman,et al.  Mechanisms underlying Children's susceptibility to environmental toxicants. , 2000, Environmental health perspectives.

[2]  James B. Adams,et al.  Mercury, Lead, and Zinc in Baby Teeth of Children with Autism Versus Controls , 2007, Journal of toxicology and environmental health. Part A.

[3]  D. Tayloe,et al.  Pediatrics , 1927, The Indian Medical Gazette.

[4]  R. Lathe,et al.  Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. , 2006, Toxicology and applied pharmacology.

[5]  Lisa K. Sykes,et al.  A Review of Thimerosal (Merthiolate) and its Ethylmercury Breakdown Product: Specific Historical Considerations Regarding Safety and Effectiveness , 2007, Journal of toxicology and environmental health. Part B, Critical reviews.

[6]  F. Serajee,et al.  Polymorphisms in Xenobiotic Metabolism Genes and Autism , 2004, Journal of child neurology.

[7]  Robert T. Chen,et al.  Utility of Large‐linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic Effects , 1995, Annals of the New York Academy of Sciences.

[8]  Zhanjun Guo,et al.  Spontaneous hypomorphic mutations in antioxidant enzymes of mice. , 2003, Free radical biology & medicine.

[9]  M Hornig,et al.  Neurotoxic effects of postnatal thimerosal are mouse strain dependent , 2004, Molecular Psychiatry.

[10]  David A Geier,et al.  A Case Series of Children with Apparent Mercury Toxic Encephalopathies Manifesting with Clinical Symptoms of Regressive Autistic Disorders , 2007, Journal of toxicology and environmental health. Part A.

[11]  Thomas Clarkson,et al.  Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal , 2005, Environmental health perspectives.

[12]  R. Copes,et al.  Thiomersal in Vaccines , 2005, Drug safety.

[13]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[14]  D. Geier,et al.  A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. , 2006, Neuro endocrinology letters.

[15]  V. Wong,et al.  Attention-Deficit Hyperactivity Disorder and Blood Mercury Level: a Case-Control Study in Chinese Children , 2006, Neuropediatrics.

[16]  W. J. Walsh,et al.  The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation , 2008 .

[17]  Zachary Stein,et al.  Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. , 2006, Health & place.

[18]  D. Geier,et al.  A Prospective Study of Mercury Toxicity Biomarkers in Autistic Spectrum Disorders , 2007, Journal of toxicology and environmental health. Part A.

[19]  Nick Andrews,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[20]  T. Shors,et al.  Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty , 2007, Journal of neurochemistry.

[21]  David A Geier,et al.  A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[22]  L. Croen,et al.  Autism Spectrum Disorders in Relation to Distribution of Hazardous Air Pollutants in the San Francisco Bay Area , 2006, Environmental health perspectives.

[23]  Bernard Rimland,et al.  Association between thimerosal-containing vaccine and autism. , 2003, JAMA.

[24]  David A. Geier,et al.  A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders , 2006, Hormone Research in Paediatrics.

[25]  Lara Delmolino,et al.  Pervasive developmental disorders , 2007 .

[26]  S. Buyske,et al.  Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. , 2007, Archives of pediatrics & adolescent medicine.

[27]  J. Prieto,et al.  A Microscopic Study of Language-Related Cortex in Autism , 2008 .

[28]  Diane Simpson,et al.  Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. , 2003, American journal of preventive medicine.

[29]  P. W. Bowman,et al.  PHS Public Health Service , 1963 .

[30]  Mark F Blaxill,et al.  Reduced Levels of Mercury in First Baby Haircuts of Autistic Children , 2003, International journal of toxicology.

[31]  David A. Geier,et al.  A prospective assessment of porphyrins in autistic disorders: A potential marker for heavy metal exposure , 2006, Neurotoxicity Research.

[32]  G. Laurell,et al.  ELEVATED BLOOD MERCURY AND NEURO-OTOLOGICAL OBSERVATIONS IN CHILDREN OF THE ECUADORIAN GOLD MINES , 2002, Journal of toxicology and environmental health. Part A.

[33]  M. Critchley.  The Journal of the Neurological Sciences , 1998, Journal of the Neurological Sciences.

[34]  David A Geier,et al.  A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[35]  J. Parkin,et al.  Route of decomposition of thiomersal (thimerosal). , 2000, International journal of pharmaceutics.

[36]  C. Rice,et al.  Prevalence of autism in a US metropolitan area. , 2003, JAMA.

[37]  P. Grandjean,et al.  Human Milk as a Source of Methylmercury Exposure in Infants. , 1994, Environmental health perspectives.

[38]  H. Windom,et al.  Oxidative Stress in Autism: Elevated Cerebellar 3-nitrotyrosine Levels , 2008 .

[39]  M. Desoto,et al.  Blood Levels of Mercury Are Related to Diagnosis of Autism: A Reanalysis of an Important Data Set , 2007, Journal of child neurology.

[40]  Esben Budtz-Jørgensen,et al.  Separation of Risks and Benefits of Seafood Intake , 2006, Environmental health perspectives.

[41]  Tracey J. Woodruff,et al.  Dose–Response Relationship of Prenatal Mercury Exposure and IQ: An Integrative Analysis of Epidemiologic Data , 2007, Environmental health perspectives.

[42]  T. Verstraeten.  Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline. , 2004, Pediatrics.

[43]  F. Perera,et al.  Effects of prenatal exposure to mercury on cognitive and psychomotor function in one-year-old infants: epidemiologic cohort study in Poland. , 2006, Annals of epidemiology.

[44]  P. Fine,et al.  Confounding in studies of adverse reactions to vaccines. , 1992, American journal of epidemiology.

[45]  Linyan Meng,et al.  Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations , 2006, Pediatrics.

[46]  R. Davis,et al.  The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. , 2000, Bulletin of the World Health Organization.

[47]  S. Plotkin,et al.  Vaccines: past, present and future , 2005, Nature Medicine.

[48]  L. Ball,et al.  An assessment of thimerosal use in childhood vaccines. , 2001, Pediatrics.

[49]  S. Buyske,et al.  Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism , 2006, BMC Genetics.

[50]  J. Heron,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Prospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[51]  Stepan Melnyk,et al.  Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[52]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.